Diaceutics PLC
Diaceutics PLC DXRX.L Peers
See (DXRX.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DXRX.L | $132.00 | +3.53% | 111.50M | -66.00 | -$0.02 | N/A |
| 0QNO.L | $575.20 | +0.87% | 40.45B | 14.55 | $39.52 | +1.04% |
| 0KHE.L | $93.65 | +1.47% | 11.04B | 15.20 | $6.16 | +0.30% |
| IDHC.L | $0.35 | -2.78% | 203.46M | 8.75 | $0.04 | N/A |
| 0G8X.L | $0.42 | +5.72% | 105.90M | -0.05 | -$7.81 | N/A |
| AGL.L | $8.00 | +3.47% | 25.80M | -1.14 | -$0.07 | N/A |
| YGEN.L | $0.51 | -0.47% | 16.37M | -0.51 | -$0.01 | N/A |
| ABDX.L | $6.10 | -1.64% | 11.81M | -6.10 | -$0.01 | N/A |
| PRM.L | $4.00 | +8.11% | 11.81M | -4.00 | -$0.01 | N/A |
| GDR.L | $1.36 | -0.03% | 8.47M | -0.68 | -$0.02 | N/A |
Stock Comparison
DXRX.L vs 0QNO.L Comparison
DXRX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXRX.L stands at 111.50M. In comparison, 0QNO.L has a market cap of 40.45B. Regarding current trading prices, DXRX.L is priced at $132.00, while 0QNO.L trades at $575.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXRX.L currently has a P/E ratio of -66.00, whereas 0QNO.L's P/E ratio is 14.55. In terms of profitability, DXRX.L's ROE is -0.07%, compared to 0QNO.L's ROE of +0.07%. Regarding short-term risk, DXRX.L is more volatile compared to 0QNO.L. This indicates potentially higher risk in terms of short-term price fluctuations for DXRX.L.